IL6 and neoplasm: A positive feedback loop between NF-κB and pro-inflammatory mediators, particularly tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and IL-1β, further amplifies chronic inflammation, perpetuating a tumour-promoting microenvironment [22].